glp 1 epilepsy can cause seizures GLP-1 receptor agonists in people with epilepsy: A scoping review of clinical data, safety, and therapeutic implications Association Between GLP-1 Receptor Agonist – Could GLP-1 Drugs Lower Epilepsy

Research has demonstrated saturation kinetics of ALCAR in HIV patients taking 3g versus 1g once daily

Ipamorelin vs Tesamorelin: The Takeaway Based on the studies we shared above, both peptides ipamorelin and tesamorelin provide similar benefits, with only subtle differences between them, including: Structure Tesamorelin and ipamorelin both stimulate the pituitary gland to produce more growth hormone

The amphibian tree of life

View image online ( Eye with uveitis Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists, commonly used to treat Type 2 diabetes and obesity, have a significantly lower risk of developing noninfectious uveitis compared with patients not taking the medication

The information on this page is for educational purposes only and does not constitute medical advice

doi: 10.1007/s12178-025-09990-7